Stock Events

Stock Events

C4 Therapeutics (CCCC) Q2 2024 Earnings

8MayConfirmed

Q2 2023

Q3 2023

Q4 2023

Q2 2024

-0.73

-0.61

-0.49

-0.36

Details

Expected EPS

-0.364852

Actual EPS

-0.41

Surprise EPS

-0.05

Surprise Percent

+12.37%

Description

C4 Therapeutics (CCCC) has reported earnings of -0.41 per share for Q2 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.